Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells.
about
Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget.Biological Effects of Naturally Occurring Sphingolipids, Uncommon Variants, and Their Analogs.Effect of sphingosine kinase modulators on interleukin-1β release, sphingosine 1-phosphate receptor 1 expression and experimental autoimmune encephalomyelitis.Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress.Mast cell chymase affects the proliferation and metastasis of lung carcinoma cells in vitro."Dicing and Splicing" Sphingosine Kinase and Relevance to Cancer.Sphingosine kinase 2 and multiple myelomaInduction of autophagy by sphingosine kinase 1 inhibitor PF-543 in head and neck squamous cell carcinoma cells.The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer.Sphingolipids and their metabolism in physiology and disease.The sphingosine kinase 2 inhibitor ABC294640 displays anti-non-small cell lung cancer activities in vitro and in vivo.Role of sphingolipids in senescence: implication in aging and age-related diseasesSynthesis and pharmacological evaluation of novel epidermal growth factor receptor inhibitors against prostate tumor cells
P2860
Q33829692-0B7D3D9A-36DB-4BEB-80ED-2FAFEABB6B98Q38890587-56E947A3-F119-41BB-A15A-70DC37FC066BQ39172652-6A718EDD-EA28-4488-A17A-7F07673E73D8Q41279386-065AF8A7-21C8-4884-B150-54BEF14F5638Q41615150-C0ED159F-8BEC-48C9-996F-D67A3C2BE8C6Q41661043-A6F4C780-143C-498C-99A8-F3FA0E0CEE27Q42343101-7F994DF7-80C8-4DA2-A758-DA92DED1BCE6Q42972395-D7D9EBBD-A58F-4C66-A6B8-831344B8911EQ47130227-B38A8101-5F6A-4465-A45A-D201C85630F7Q47374235-1131A674-751C-4F9F-8CE9-6F0A44E31935Q48349932-32537C30-A65E-4DAD-BDB5-AAC8044E9F33Q57177438-E3271029-CCD5-4590-83A6-1381365B3DBDQ58572503-BEB907EB-C5B9-4463-99A3-B8DD982A49B2
P2860
Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Proteasomal degradation of sph ...... NCaP-AI prostate cancer cells.
@en
Proteasomal degradation of sph ...... NCaP-AI prostate cancer cells.
@nl
type
label
Proteasomal degradation of sph ...... NCaP-AI prostate cancer cells.
@en
Proteasomal degradation of sph ...... NCaP-AI prostate cancer cells.
@nl
prefLabel
Proteasomal degradation of sph ...... NCaP-AI prostate cancer cells.
@en
Proteasomal degradation of sph ...... NCaP-AI prostate cancer cells.
@nl
P2093
P2860
P356
P1433
P1476
Proteasomal degradation of sph ...... NCaP-AI prostate cancer cells.
@en
P2093
Melissa McNaughton
Melissa Pitman
Nigel J Pyne
Susan Pyne
P2860
P304
16663-16675
P356
10.18632/ONCOTARGET.7693
P407
P577
2016-02-25T00:00:00Z